Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Obstetrics

What Does Low uE3 on a Prenatal Screen Mean for RXLI?

At a Glance

A very low uE3 (unconjugated estriol) level on a prenatal screen is a strong indicator that a male fetus may have Recessive X-linked Ichthyosis (RXLI). Because low uE3 can have other causes, further genetic testing, like amniocentesis, is required to confirm the diagnosis.

In this answer

4 sections

01

Why uE3 is Low in RXLI

02

Is it Definitely RXLI?

03

Next Steps for Confirmation

04

What This Means for Your Pregnancy

If your prenatal screening shows very low levels of unconjugated estriol (uE3), it is a strong indicator that a male fetus may have Recessive X-linked Ichthyosis (RXLI), but it is not a definitive diagnosis. During pregnancy, the placenta uses an enzyme called steroid sulfatase (STS) to produce estriol. In RXLI, a genetic change causes a deficiency of this enzyme, leading to extremely low uE3 levels in the mother’s blood [1][2]. However, because low uE3 is a screening result and can be caused by other conditions, further genetic testing is required to confirm whether the baby actually has RXLI [1].

Why uE3 is Low in RXLI

The STS enzyme acts like a key that unlocks hormones needed during pregnancy. When the fetus has the genetic change that causes RXLI (typically a missing or altered STS gene), the placenta cannot produce enough of this enzyme [3][4]. As a result, the precursor hormones are not converted into estriol, and the mother’s uE3 levels drop significantly, often below 0.3 MoM (multiples of the median, which is how labs compare your levels to an average pregnancy) [5][1]. Because RXLI is an X-linked condition, it primarily affects male fetuses, making the baby’s sex an important piece of the puzzle.

Is it Definitely RXLI?

No. A low uE3 level is a “red flag” that prompts your doctor to investigate further, but it does not guarantee your baby has RXLI [1].

While STS deficiency is a common cause of very low uE3, other possibilities include:

  • Smith-Lemli-Opitz syndrome (SLOS): Another rare genetic condition that affects how the body processes cholesterol [1][2].
  • Fetal growth restriction: Low uE3 can sometimes be a sign that the baby is simply smaller than expected [5][6].
  • Lab interference: Certain anti-seizure medications or even natural antibodies in the mother’s blood can sometimes interfere with the lab test, causing a falsely low reading [7][8].

Next Steps for Confirmation

To find out for sure what is causing the low uE3, your care team will likely recommend further testing:

  • Detailed Ultrasound: To check the baby’s growth and look for any physical signs of other conditions.
  • Non-Invasive Prenatal Testing (NIPT): A simple blood test from the mother that analyzes the baby’s DNA circulating in her blood. Some advanced or “expanded” NIPTs can screen for the specific missing piece of DNA (microdeletion) that causes RXLI [5][9]. However, NIPT is still considered a screening test, not a diagnostic one [10][11].
  • Amniocentesis with Chromosomal Microarray (CMA): This is the definitive diagnostic test. A small amount of amniotic fluid is drawn to look directly at the baby’s chromosomes. CMA can accurately detect the specific deletion causing STS deficiency and check if neighboring genes are also affected. This is important for identifying related conditions like Kallmann syndrome, which can affect puberty and the sense of smell [12][13]. Invasive tests like amniocentesis are considered the gold standard for confirming abnormal screening results [14][11].

What This Means for Your Pregnancy

If genetic testing confirms that your baby has RXLI, the primary concern for the rest of your pregnancy involves labor and delivery. The same STS enzyme deficiency that causes low uE3 also plays a role in preparing the body for labor. Mothers carrying a baby with RXLI have a higher chance of prolonged labor or labor that does not start on its own, which may require a planned induction or a Cesarean section [15]. Knowing this in advance allows your obstetrics team to plan the safest delivery for you and your baby.

Common questions in this guide

What causes low uE3 on a prenatal screen?
Low uE3 happens when the placenta cannot produce enough of an enzyme called steroid sulfatase (STS). This is often caused by a genetic change in the fetus, such as Recessive X-linked Ichthyosis (RXLI), but it can also be due to a smaller-than-expected baby, other rare syndromes, or lab interference.
Does low uE3 mean my baby definitely has RXLI?
No, a low uE3 level is a screening result that acts as a red flag, but it does not guarantee a diagnosis. Your doctor will likely recommend further testing, like an advanced NIPT or amniocentesis, to confirm if your baby actually has RXLI.
What is the most accurate test for RXLI during pregnancy?
The most definitive diagnostic test for RXLI is an amniocentesis with chromosomal microarray (CMA). This test looks directly at the baby's chromosomes to find the specific genetic deletion that causes steroid sulfatase deficiency.
Can low uE3 affect my labor and delivery?
Yes, if the low uE3 is caused by RXLI. The enzyme deficiency that lowers uE3 levels also plays a role in preparing your body for labor, meaning mothers carrying a baby with RXLI have a higher chance of prolonged labor or needing an induction or C-section.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my exact uE3 level (the MoM value), and how does it compare to typical levels?
  2. 2.Should I be referred to a genetic counselor or a Maternal-Fetal Medicine (MFM) specialist to discuss these results?
  3. 3.If I choose to do an expanded NIPT, how accurate is it at detecting the specific microdeletion for RXLI?
  4. 4.What are the risks of waiting versus proceeding with an amniocentesis right away?
  5. 5.How does this screening result change our birth plan, and should we discuss scheduling an induction or C-section?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Females Have Recessive X-Linked Ichthyosis Symptoms?Do Eye Spots in X-Linked Ichthyosis Affect Vision?Does Recessive X-Linked Ichthyosis Improve With Age?How Is Recessive X-Linked Ichthyosis Inherited from Fathers?How Do Teens Cope With Recessive X-Linked Ichthyosis?Is ADHD Related to Recessive X-Linked Ichthyosis?Is Salicylic Acid Safe for Children with RXLI?What Are the Best Bath Additives for RXLI Scales?What Are RXLI Pregnancy Labor Complications?What Are Oral Retinoid Side Effects for RXLI?What is contiguous gene syndrome in X-linked Ichthyosis?RXLI vs. Ichthyosis Vulgaris: What's the Difference?What Is the Risk of Atrial Fibrillation With RXLI?Why Does Recessive X-Linked Ichthyosis Cause Low Vitamin D?

References

References (15)
  1. 1

    How to Manage Low Estriol Levels in Pregnancies, One Center Experience.

    Yilmaz Gulec E, Gezdirici A, Ayaz A, et al.

    Medeniyet medical journal 2022; (37(1)):62-70 doi:10.4274/MMJ.galenos.2022.22747.

    PMID: 35306787
  2. 2

    [Early warning of low maternal unconjugated estriol level by prenatal screening for fetus with X-linked ichthyosis].

    Liu HY, Li J, Huang DR, et al.

    Zhonghua fu chan ke za zhi 2022; (57(6)):407-412 doi:10.3760/cma.j.cn112141-20220125-00043.

    PMID: 35775247
  3. 3

    X-linked ichthyosis: Molecular findings in four pedigrees with inconspicuous clinical manifestations.

    Zhang M, Huang H, Lin N, et al.

    Journal of clinical laboratory analysis 2020; (34(5)):e23201 doi:10.1002/jcla.23201.

    PMID: 31944387
  4. 4

    Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis.

    Williams D, Onyia O, Chung DD, et al.

    Molecular vision 2023; (29()):25-30.

    PMID: 37287641
  5. 5

    Prenatal Screening for Fetal X-Linked Ichthyosis: A Large Cohort Study Combining Non-Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis.

    Han M, Chen M, Du Y, et al.

    Prenatal diagnosis 2026; (46(7)):1000-1007 doi:10.1002/pd.70139.

    PMID: 41888405
  6. 6

    Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes.

    Settiyanan T, Wanapirak C, Sirichotiyakul S, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2016; (29(13)):2093-7 doi:10.3109/14767058.2015.1075503.

    PMID: 27480207
  7. 7

    Effects of Antiseizure Medications on Second-Trimester Prenatal Screening Test Parameters: A Retrospective Cohort Study.

    Golgelioglu M, Akcabay C, Albayrak GS, Telo S

    Medicina (Kaunas, Lithuania) 2025; (61(6)) doi:10.3390/medicina61061101.

    PMID: 40572789
  8. 8

    Detection and characterization of estradiol (E2) and unconjugated estriol (uE3) immunoassay interference due to anti-bovine alkaline phosphatase (ALP) antibodies.

    Maharjan AS, Wyness SP, Ray JA, et al.

    Practical laboratory medicine 2019; (17()):e00131 doi:10.1016/j.plabm.2019.e00131.

    PMID: 31538105
  9. 9

    Clinical experience of genome-wide non-invasive prenatal testing as a first-tier screening test in a cohort of 59,771 pregnancies.

    Zhen J, Zhang L, Wang H, et al.

    PloS one 2025; (20(8)):e0329463 doi:10.1371/journal.pone.0329463.

    PMID: 40824895
  10. 10

    The Impact of Chromosomal Mosaicisms on Prenatal Diagnosis and Genetic Counseling-A Narrative Review.

    Militaru MS, Babliuc IM, Bloaje-Florică VL, et al.

    Journal of personalized medicine 2024; (14(7)) doi:10.3390/jpm14070774.

    PMID: 39064028
  11. 11

    Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing.

    Gug M, Rațiu A, Andreescu N, et al.

    Journal of personalized medicine 2024; (14(4)) doi:10.3390/jpm14040366.

    PMID: 38672993
  12. 12

    Comprehensive chromosomal abnormality detection: integrating CNV-Seq with traditional karyotyping in prenatal diagnostics.

    Huang Y, Fu S, Shao D, et al.

    BMC medical genomics 2025; (18(1)):81 doi:10.1186/s12920-025-02139-y.

    PMID: 40301840
  13. 13

    Kallmann syndrome and ichthyosis: a case of contiguous gene deletion syndrome.

    Berges-Raso I, Giménez-Palop O, Gabau E, et al.

    Endocrinology, diabetes & metabolism case reports 2017; (2017()).

    PMID: 30352392
  14. 14

    Chromosomal Microarray Analysis Compared With Noninvasive Prenatal Testing in Pregnancies With Abnormal Maternal Serum Screening.

    Sagi-Dain L, Salzer Sheelo L, Brabbing-Goldstein D, et al.

    Obstetrics and gynecology 2022; (139(5)):877-887 doi:10.1097/AOG.0000000000004758.

    PMID: 35576346
  15. 15

    X-linked Ichthyosis Presenting as Erythroderma: A Rare Case.

    Das A, Mishra V, Shome K, Sen A

    Indian journal of dermatology 2015; (60(5)):491-3 doi:10.4103/0019-5154.164372.

    PMID: 26538699

This page is for educational purposes and does not replace professional medical advice. Always consult your obstetrician or maternal-fetal medicine specialist to interpret your specific prenatal screening results.

Get notified when new evidence is published on Recessive X-linked ichthyosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.